大勝達(603687.SH):與浙江數字內容研究院等等簽訂戰略合作框架協議
格隆匯1月21日丨大勝達(603687.SH)公佈,公司與浙江數字內容研究院、電子科技大學(深圳)高等研究院、浙江省北大信息技術高等研究院簽訂的《戰略合作框架協議》,屬於四方合作意願和基本原則的框架性、意向性的約定、不構成強制的法律約束,亦不構成協議雙方相互追究違約責任的依據。
此次合作建立“聯合科研平台”,主要是為研究提供數字經濟中5G工業互聯網的整體解決方案和其中技術問題。公吿中涉及的“聯合科研平台”尚處於研發和初創階段,公司預計每年提供不低於500萬元經費給聯合研發平台,未來運營收入存在很大不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.